EndoShape is in the process of raising $6.8 million in the latest reported funding round for the minimally invasive vessel occlusion devices maker.
The company has raised over $5.8 million so far from 17 unnamed investors, according to regulatory filings updated yesterday. EndoShape launched the equity funding round on June 10, 2014, adding to nearly $900,000 the company raised in January.
The device maker, headquartered in Boulder, Colo., develops minimally invasive plugs and coils for occluding blood vessels. The technologies leverage EndoShape’s proprietary "memory polymers" that the company hopes will "revolutionize minimally invasive treatment and endolumenal applications."
EndoShape won FDA clearance in November for its Medusa vascular plug, with indication for arterial and venous embolization in the peripheral vasculature.
The company has just under $1 million left to raise before closing the books on its latest funding round, according to an SEC filing. EndoShape didn’t disclose names of the 17 listed participants in the round, but previous backers include High Country Venture and Volcano Capital, according to the website.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.